Investor Relations
Mar 21, 2019
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial MORE >>
Feb 27, 2019
OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2019
OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019 MORE >>
Feb 05, 2019
OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>

SEC Filings

Form Description Filing date View
SC 13D/A

An amendment to a SC 13D filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
5

Annual filing director officer or owner of more than ten percent.

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
8-K

Report of unscheduled material events or corporate event

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
424B2

Form of prospectus filed in connection with primary offering of securities on a delayed basis

View HTML
FWP

FWP

View HTML
424B7

424B7    

View HTML
4/A

Amendment to a previously filed 4

View HTML